img

Global Inhalation Anesthetic Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Inhalation Anesthetic Market Insights, Forecast to 2034

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Inhalation Anesthetic estimated at US$ 1284.6 million in the year 2022, is projected to reach a revised size of US$ 1524.1 million by 2028, growing at a CAGR of 2.9% during the forecast period 2022-2028.
The USA market for Inhalation Anesthetic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2024 through 2028.
The China market for Inhalation Anesthetic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2024 through 2028.
The Europe market for Inhalation Anesthetic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2024 through 2028.
The global key manufacturers of Inhalation Anesthetic include AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, Braun, Maruishi, Piramal Healthcare, Hikma Pharmaceuticals and Mylan, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Inhalation Anesthetic manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Inhalation Anesthetic market. Further, it explains the major drivers and regional dynamics of the global Inhalation Anesthetic market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report
AstraZeneca
Fresenius-Kabi
BbVie Laboratories
Baxter Healthcare
Braun
Maruishi
Piramal Healthcare
Hikma Pharmaceuticals
Mylan
Nhwa
Lunan
Hengrui
Anesthesia Reclamation
Deltasorb Technologies (Blue Zone Technology)
Market Segments
This report has explored the key segmentsby Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Inhalation Anesthetic Segment by Type
Sevoflurane
Isoflurane
Desflurane
Others
Inhalation Anesthetic

Segment by Application


Hospital Use
Clinic Use
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Inhalation Anesthetic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes


This report presents an overview of global market for Inhalation Anesthetic, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Inhalation Anesthetic, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Inhalation Anesthetic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Inhalation Anesthetic sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Inhalation Anesthetic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Inhalation Anesthetic sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, Braun, Maruishi, Piramal Healthcare, Hikma Pharmaceuticals and Mylan, etc.

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Inhalation Anesthetic in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Inhalation Anesthetic manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhalation Anesthetic sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Inhalation Anesthetic Product Introduction
1.2 Market by Type
1.2.1 Global Inhalation Anesthetic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sevoflurane
1.2.3 Isoflurane
1.2.4 Desflurane
1.2.5 Others
1.3 Market by Application
1.3.1 Global Inhalation Anesthetic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Use
1.3.3 Clinic Use
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Inhalation Anesthetic Sales Estimates and Forecasts 2017-2028
2.2 Global Inhalation Anesthetic Revenue Estimates and Forecasts 2017-2028
2.3 Global Inhalation Anesthetic Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Inhalation Anesthetic Sales by Region
2.4.1 Global Inhalation Anesthetic Sales by Region (2017-2022)
2.4.2 Global Sales Inhalation Anesthetic by Region (2024-2028)
2.5 Global Inhalation Anesthetic Revenue by Region
2.5.1 Global Inhalation Anesthetic Revenue by Region (2017-2022)
2.5.2 Global Inhalation Anesthetic Revenue by Region (2024-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Inhalation Anesthetic Sales by Manufacturers
3.1.1 Global Top Inhalation Anesthetic Manufacturers by Sales (2017-2022)
3.1.2 Global Inhalation Anesthetic Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inhalation Anesthetic in 2021
3.2 Global Inhalation Anesthetic Revenue by Manufacturers
3.2.1 Global Inhalation Anesthetic Revenue by Manufacturers (2017-2022)
3.2.2 Global Inhalation Anesthetic Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Inhalation Anesthetic Revenue in 2021
3.3 Global Inhalation Anesthetic Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Inhalation Anesthetic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Inhalation Anesthetic Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inhalation Anesthetic Sales by Type
4.1.1 Global Inhalation Anesthetic Historical Sales by Type (2017-2022)
4.1.2 Global Inhalation Anesthetic Forecasted Sales by Type (2024-2028)
4.1.3 Global Inhalation Anesthetic Sales Market Share by Type (2017-2028)
4.2 Global Inhalation Anesthetic Revenue by Type
4.2.1 Global Inhalation Anesthetic Historical Revenue by Type (2017-2022)
4.2.2 Global Inhalation Anesthetic Forecasted Revenue by Type (2024-2028)
4.2.3 Global Inhalation Anesthetic Revenue Market Share by Type (2017-2028)
4.3 Global Inhalation Anesthetic Price by Type
4.3.1 Global Inhalation Anesthetic Price by Type (2017-2022)
4.3.2 Global Inhalation Anesthetic Price Forecast by Type (2024-2028)
5 Market Size by Application
5.1 Global Inhalation Anesthetic Sales by Application
5.1.1 Global Inhalation Anesthetic Historical Sales by Application (2017-2022)
5.1.2 Global Inhalation Anesthetic Forecasted Sales by Application (2024-2028)
5.1.3 Global Inhalation Anesthetic Sales Market Share by Application (2017-2028)
5.2 Global Inhalation Anesthetic Revenue by Application
5.2.1 Global Inhalation Anesthetic Historical Revenue by Application (2017-2022)
5.2.2 Global Inhalation Anesthetic Forecasted Revenue by Application (2024-2028)
5.2.3 Global Inhalation Anesthetic Revenue Market Share by Application (2017-2028)
5.3 Global Inhalation Anesthetic Price by Application
5.3.1 Global Inhalation Anesthetic Price by Application (2017-2022)
5.3.2 Global Inhalation Anesthetic Price Forecast by Application (2024-2028)
6 North America
6.1 North America Inhalation Anesthetic Market Size by Type
6.1.1 North America Inhalation Anesthetic Sales by Type (2017-2028)
6.1.2 North America Inhalation Anesthetic Revenue by Type (2017-2028)
6.2 North America Inhalation Anesthetic Market Size by Application
6.2.1 North America Inhalation Anesthetic Sales by Application (2017-2028)
6.2.2 North America Inhalation Anesthetic Revenue by Application (2017-2028)
6.3 North America Inhalation Anesthetic Market Size by Country
6.3.1 North America Inhalation Anesthetic Sales by Country (2017-2028)
6.3.2 North America Inhalation Anesthetic Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Inhalation Anesthetic Market Size by Type
7.1.1 Europe Inhalation Anesthetic Sales by Type (2017-2028)
7.1.2 Europe Inhalation Anesthetic Revenue by Type (2017-2028)
7.2 Europe Inhalation Anesthetic Market Size by Application
7.2.1 Europe Inhalation Anesthetic Sales by Application (2017-2028)
7.2.2 Europe Inhalation Anesthetic Revenue by Application (2017-2028)
7.3 Europe Inhalation Anesthetic Market Size by Country
7.3.1 Europe Inhalation Anesthetic Sales by Country (2017-2028)
7.3.2 Europe Inhalation Anesthetic Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Inhalation Anesthetic Market Size by Type
8.1.1 Asia Pacific Inhalation Anesthetic Sales by Type (2017-2028)
8.1.2 Asia Pacific Inhalation Anesthetic Revenue by Type (2017-2028)
8.2 Asia Pacific Inhalation Anesthetic Market Size by Application
8.2.1 Asia Pacific Inhalation Anesthetic Sales by Application (2017-2028)
8.2.2 Asia Pacific Inhalation Anesthetic Revenue by Application (2017-2028)
8.3 Asia Pacific Inhalation Anesthetic Market Size by Region
8.3.1 Asia Pacific Inhalation Anesthetic Sales by Region (2017-2028)
8.3.2 Asia Pacific Inhalation Anesthetic Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Inhalation Anesthetic Market Size by Type
9.1.1 Latin America Inhalation Anesthetic Sales by Type (2017-2028)
9.1.2 Latin America Inhalation Anesthetic Revenue by Type (2017-2028)
9.2 Latin America Inhalation Anesthetic Market Size by Application
9.2.1 Latin America Inhalation Anesthetic Sales by Application (2017-2028)
9.2.2 Latin America Inhalation Anesthetic Revenue by Application (2017-2028)
9.3 Latin America Inhalation Anesthetic Market Size by Country
9.3.1 Latin America Inhalation Anesthetic Sales by Country (2017-2028)
9.3.2 Latin America Inhalation Anesthetic Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Inhalation Anesthetic Market Size by Type
10.1.1 Middle East and Africa Inhalation Anesthetic Sales by Type (2017-2028)
10.1.2 Middle East and Africa Inhalation Anesthetic Revenue by Type (2017-2028)
10.2 Middle East and Africa Inhalation Anesthetic Market Size by Application
10.2.1 Middle East and Africa Inhalation Anesthetic Sales by Application (2017-2028)
10.2.2 Middle East and Africa Inhalation Anesthetic Revenue by Application (2017-2028)
10.3 Middle East and Africa Inhalation Anesthetic Market Size by Country
10.3.1 Middle East and Africa Inhalation Anesthetic Sales by Country (2017-2028)
10.3.2 Middle East and Africa Inhalation Anesthetic Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AstraZeneca Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Fresenius-Kabi
11.2.1 Fresenius-Kabi Corporation Information
11.2.2 Fresenius-Kabi Overview
11.2.3 Fresenius-Kabi Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Fresenius-Kabi Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Fresenius-Kabi Recent Developments
11.3 BbVie Laboratories
11.3.1 BbVie Laboratories Corporation Information
11.3.2 BbVie Laboratories Overview
11.3.3 BbVie Laboratories Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BbVie Laboratories Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BbVie Laboratories Recent Developments
11.4 Baxter Healthcare
11.4.1 Baxter Healthcare Corporation Information
11.4.2 Baxter Healthcare Overview
11.4.3 Baxter Healthcare Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Baxter Healthcare Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Baxter Healthcare Recent Developments
11.5 Braun
11.5.1 Braun Corporation Information
11.5.2 Braun Overview
11.5.3 Braun Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Braun Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Braun Recent Developments
11.6 Maruishi
11.6.1 Maruishi Corporation Information
11.6.2 Maruishi Overview
11.6.3 Maruishi Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Maruishi Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Maruishi Recent Developments
11.7 Piramal Healthcare
11.7.1 Piramal Healthcare Corporation Information
11.7.2 Piramal Healthcare Overview
11.7.3 Piramal Healthcare Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Piramal Healthcare Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Piramal Healthcare Recent Developments
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Corporation Information
11.8.2 Hikma Pharmaceuticals Overview
11.8.3 Hikma Pharmaceuticals Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Hikma Pharmaceuticals Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hikma Pharmaceuticals Recent Developments
11.9 Mylan
11.9.1 Mylan Corporation Information
11.9.2 Mylan Overview
11.9.3 Mylan Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Mylan Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Mylan Recent Developments
11.10 Nhwa
11.10.1 Nhwa Corporation Information
11.10.2 Nhwa Overview
11.10.3 Nhwa Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Nhwa Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nhwa Recent Developments
11.11 Lunan
11.11.1 Lunan Corporation Information
11.11.2 Lunan Overview
11.11.3 Lunan Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Lunan Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lunan Recent Developments
11.12 Hengrui
11.12.1 Hengrui Corporation Information
11.12.2 Hengrui Overview
11.12.3 Hengrui Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Hengrui Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Hengrui Recent Developments
11.13 Anesthesia Reclamation
11.13.1 Anesthesia Reclamation Corporation Information
11.13.2 Anesthesia Reclamation Overview
11.13.3 Anesthesia Reclamation Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Anesthesia Reclamation Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Anesthesia Reclamation Recent Developments
11.14 Deltasorb Technologies (Blue Zone Technology)
11.14.1 Deltasorb Technologies (Blue Zone Technology) Corporation Information
11.14.2 Deltasorb Technologies (Blue Zone Technology) Overview
11.14.3 Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Deltasorb Technologies (Blue Zone Technology) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inhalation Anesthetic Industry Chain Analysis
12.2 Inhalation Anesthetic Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inhalation Anesthetic Production Mode & Process
12.4 Inhalation Anesthetic Sales and Marketing
12.4.1 Inhalation Anesthetic Sales Channels
12.4.2 Inhalation Anesthetic Distributors
12.5 Inhalation Anesthetic Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Inhalation Anesthetic Industry Trends
13.2 Inhalation Anesthetic Market Drivers
13.3 Inhalation Anesthetic Market Challenges
13.4 Inhalation Anesthetic Market Restraints
14 Key Findings in The Global Inhalation Anesthetic Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Inhalation Anesthetic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Sevoflurane
Table 3. Major Manufacturers of Isoflurane
Table 4. Major Manufacturers of Desflurane
Table 5. Major Manufacturers of Others
Table 6. Global Inhalation Anesthetic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Inhalation Anesthetic Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Inhalation Anesthetic Sales by Region (2017-2022) & (K MT)
Table 9. Global Inhalation Anesthetic Sales Market Share by Region (2017-2022)
Table 10. Global Inhalation Anesthetic Sales by Region (2024-2028) & (K MT)
Table 11. Global Inhalation Anesthetic Sales Market Share by Region (2024-2028)
Table 12. Global Inhalation Anesthetic Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Inhalation Anesthetic Revenue Market Share by Region (2017-2022)
Table 14. Global Inhalation Anesthetic Revenue by Region (2024-2028) & (US$ Million)
Table 15. Global Inhalation Anesthetic Revenue Market Share by Region (2024-2028)
Table 16. Global Inhalation Anesthetic Sales by Manufacturers (2017-2022) & (K MT)
Table 17. Global Inhalation Anesthetic Sales Share by Manufacturers (2017-2022)
Table 18. Global Inhalation Anesthetic Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Inhalation Anesthetic Revenue Share by Manufacturers (2017-2022)
Table 20. Inhalation Anesthetic Price by Manufacturers (2017-2022) &(USD/MT)
Table 21. Global Inhalation Anesthetic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Inhalation Anesthetic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalation Anesthetic as of 2021)
Table 23. Inhalation Anesthetic Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Inhalation Anesthetic Product Offered
Table 25. Date of Manufacturers Enter into Inhalation Anesthetic Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Inhalation Anesthetic Sales by Type (2017-2022) & (K MT)
Table 28. Global Inhalation Anesthetic Sales by Type (2024-2028) & (K MT)
Table 29. Global Inhalation Anesthetic Sales Share by Type (2017-2022)
Table 30. Global Inhalation Anesthetic Sales Share by Type (2024-2028)
Table 31. Global Inhalation Anesthetic Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Inhalation Anesthetic Revenue by Type (2024-2028) & (US$ Million)
Table 33. Global Inhalation Anesthetic Revenue Share by Type (2017-2022)
Table 34. Global Inhalation Anesthetic Revenue Share by Type (2024-2028)
Table 35. Inhalation Anesthetic Price by Type (2017-2022) & (USD/MT)
Table 36. Global Inhalation Anesthetic Price Forecast by Type (2024-2028) & (USD/MT)
Table 37. Global Inhalation Anesthetic Sales by Application (2017-2022) & (K MT)
Table 38. Global Inhalation Anesthetic Sales by Application (2024-2028) & (K MT)
Table 39. Global Inhalation Anesthetic Sales Share by Application (2017-2022)
Table 40. Global Inhalation Anesthetic Sales Share by Application (2024-2028)
Table 41. Global Inhalation Anesthetic Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Inhalation Anesthetic Revenue by Application (2024-2028) & (US$ Million)
Table 43. Global Inhalation Anesthetic Revenue Share by Application (2017-2022)
Table 44. Global Inhalation Anesthetic Revenue Share by Application (2024-2028)
Table 45. Inhalation Anesthetic Price by Application (2017-2022) & (USD/MT)
Table 46. Global Inhalation Anesthetic Price Forecast by Application (2024-2028) & (USD/MT)
Table 47. North America Inhalation Anesthetic Sales by Type (2017-2022) & (K MT)
Table 48. North America Inhalation Anesthetic Sales by Type (2024-2028) & (K MT)
Table 49. North America Inhalation Anesthetic Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Inhalation Anesthetic Revenue by Type (2024-2028) & (US$ Million)
Table 51. North America Inhalation Anesthetic Sales by Application (2017-2022) & (K MT)
Table 52. North America Inhalation Anesthetic Sales by Application (2024-2028) & (K MT)
Table 53. North America Inhalation Anesthetic Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Inhalation Anesthetic Revenue by Application (2024-2028) & (US$ Million)
Table 55. North America Inhalation Anesthetic Sales by Country (2017-2022) & (K MT)
Table 56. North America Inhalation Anesthetic Sales by Country (2024-2028) & (K MT)
Table 57. North America Inhalation Anesthetic Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Inhalation Anesthetic Revenue by Country (2024-2028) & (US$ Million)
Table 59. Europe Inhalation Anesthetic Sales by Type (2017-2022) & (K MT)
Table 60. Europe Inhalation Anesthetic Sales by Type (2024-2028) & (K MT)
Table 61. Europe Inhalation Anesthetic Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Inhalation Anesthetic Revenue by Type (2024-2028) & (US$ Million)
Table 63. Europe Inhalation Anesthetic Sales by Application (2017-2022) & (K MT)
Table 64. Europe Inhalation Anesthetic Sales by Application (2024-2028) & (K MT)
Table 65. Europe Inhalation Anesthetic Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Inhalation Anesthetic Revenue by Application (2024-2028) & (US$ Million)
Table 67. Europe Inhalation Anesthetic Sales by Country (2017-2022) & (K MT)
Table 68. Europe Inhalation Anesthetic Sales by Country (2024-2028) & (K MT)
Table 69. Europe Inhalation Anesthetic Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Inhalation Anesthetic Revenue by Country (2024-2028) & (US$ Million)
Table 71. Asia Pacific Inhalation Anesthetic Sales by Type (2017-2022) & (K MT)
Table 72. Asia Pacific Inhalation Anesthetic Sales by Type (2024-2028) & (K MT)
Table 73. Asia Pacific Inhalation Anesthetic Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Inhalation Anesthetic Revenue by Type (2024-2028) & (US$ Million)
Table 75. Asia Pacific Inhalation Anesthetic Sales by Application (2017-2022) & (K MT)
Table 76. Asia Pacific Inhalation Anesthetic Sales by Application (2024-2028) & (K MT)
Table 77. Asia Pacific Inhalation Anesthetic Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Inhalation Anesthetic Revenue by Application (2024-2028) & (US$ Million)
Table 79. Asia Pacific Inhalation Anesthetic Sales by Region (2017-2022) & (K MT)
Table 80. Asia Pacific Inhalation Anesthetic Sales by Region (2024-2028) & (K MT)
Table 81. Asia Pacific Inhalation Anesthetic Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Inhalation Anesthetic Revenue by Region (2024-2028) & (US$ Million)
Table 83. Latin America Inhalation Anesthetic Sales by Type (2017-2022) & (K MT)
Table 84. Latin America Inhalation Anesthetic Sales by Type (2024-2028) & (K MT)
Table 85. Latin America Inhalation Anesthetic Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Inhalation Anesthetic Revenue by Type (2024-2028) & (US$ Million)
Table 87. Latin America Inhalation Anesthetic Sales by Application (2017-2022) & (K MT)
Table 88. Latin America Inhalation Anesthetic Sales by Application (2024-2028) & (K MT)
Table 89. Latin America Inhalation Anesthetic Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Inhalation Anesthetic Revenue by Application (2024-2028) & (US$ Million)
Table 91. Latin America Inhalation Anesthetic Sales by Country (2017-2022) & (K MT)
Table 92. Latin America Inhalation Anesthetic Sales by Country (2024-2028) & (K MT)
Table 93. Latin America Inhalation Anesthetic Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Inhalation Anesthetic Revenue by Country (2024-2028) & (US$ Million)
Table 95. Middle East and Africa Inhalation Anesthetic Sales by Type (2017-2022) & (K MT)
Table 96. Middle East and Africa Inhalation Anesthetic Sales by Type (2024-2028) & (K MT)
Table 97. Middle East and Africa Inhalation Anesthetic Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Inhalation Anesthetic Revenue by Type (2024-2028) & (US$ Million)
Table 99. Middle East and Africa Inhalation Anesthetic Sales by Application (2017-2022) & (K MT)
Table 100. Middle East and Africa Inhalation Anesthetic Sales by Application (2024-2028) & (K MT)
Table 101. Middle East and Africa Inhalation Anesthetic Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Inhalation Anesthetic Revenue by Application (2024-2028) & (US$ Million)
Table 103. Middle East and Africa Inhalation Anesthetic Sales by Country (2017-2022) & (K MT)
Table 104. Middle East and Africa Inhalation Anesthetic Sales by Country (2024-2028) & (K MT)
Table 105. Middle East and Africa Inhalation Anesthetic Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Inhalation Anesthetic Revenue by Country (2024-2028) & (US$ Million)
Table 107. AstraZeneca Corporation Information
Table 108. AstraZeneca Description and Major Businesses
Table 109. AstraZeneca Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 110. AstraZeneca Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. AstraZeneca Recent Developments
Table 112. Fresenius-Kabi Corporation Information
Table 113. Fresenius-Kabi Description and Major Businesses
Table 114. Fresenius-Kabi Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. Fresenius-Kabi Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Fresenius-Kabi Recent Developments
Table 117. BbVie Laboratories Corporation Information
Table 118. BbVie Laboratories Description and Major Businesses
Table 119. BbVie Laboratories Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. BbVie Laboratories Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. BbVie Laboratories Recent Developments
Table 122. Baxter Healthcare Corporation Information
Table 123. Baxter Healthcare Description and Major Businesses
Table 124. Baxter Healthcare Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 125. Baxter Healthcare Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Baxter Healthcare Recent Developments
Table 127. Braun Corporation Information
Table 128. Braun Description and Major Businesses
Table 129. Braun Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 130. Braun Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Braun Recent Developments
Table 132. Maruishi Corporation Information
Table 133. Maruishi Description and Major Businesses
Table 134. Maruishi Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 135. Maruishi Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Maruishi Recent Developments
Table 137. Piramal Healthcare Corporation Information
Table 138. Piramal Healthcare Description and Major Businesses
Table 139. Piramal Healthcare Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 140. Piramal Healthcare Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Piramal Healthcare Recent Developments
Table 142. Hikma Pharmaceuticals Corporation Information
Table 143. Hikma Pharmaceuticals Description and Major Businesses
Table 144. Hikma Pharmaceuticals Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 145. Hikma Pharmaceuticals Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Hikma Pharmaceuticals Recent Developments
Table 147. Mylan Corporation Information
Table 148. Mylan Description and Major Businesses
Table 149. Mylan Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 150. Mylan Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Mylan Recent Developments
Table 152. Nhwa Corporation Information
Table 153. Nhwa Description and Major Businesses
Table 154. Nhwa Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 155. Nhwa Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Nhwa Recent Developments
Table 157. Lunan Corporation Information
Table 158. Lunan Description and Major Businesses
Table 159. Lunan Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 160. Lunan Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Lunan Recent Developments
Table 162. Hengrui Corporation Information
Table 163. Hengrui Description and Major Businesses
Table 164. Hengrui Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 165. Hengrui Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Hengrui Recent Developments
Table 167. Anesthesia Reclamation Corporation Information
Table 168. Anesthesia Reclamation Description and Major Businesses
Table 169. Anesthesia Reclamation Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 170. Anesthesia Reclamation Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Anesthesia Reclamation Recent Developments
Table 172. Deltasorb Technologies (Blue Zone Technology) Corporation Information
Table 173. Deltasorb Technologies (Blue Zone Technology) Description and Major Businesses
Table 174. Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 175. Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Deltasorb Technologies (Blue Zone Technology) Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Inhalation Anesthetic Distributors List
Table 180. Inhalation Anesthetic Customers List
Table 181. Inhalation Anesthetic Market Trends
Table 182. Inhalation Anesthetic Market Drivers
Table 183. Inhalation Anesthetic Market Challenges
Table 184. Inhalation Anesthetic Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhalation Anesthetic Product Picture
Figure 2. Global Inhalation Anesthetic Market Share by Type in 2021 & 2028
Figure 3. Sevoflurane Product Picture
Figure 4. Isoflurane Product Picture
Figure 5. Desflurane Product Picture
Figure 6. Others Product Picture
Figure 7. Global Inhalation Anesthetic Market Share by Application in 2021 & 2028
Figure 8. Hospital Use
Figure 9. Clinic Use
Figure 10. Inhalation Anesthetic Report Years Considered
Figure 11. Global Inhalation Anesthetic Sales 2017-2028 (K MT)
Figure 12. Global Inhalation Anesthetic Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Inhalation Anesthetic Revenue 2017-2028 (US$ Million)
Figure 14. Global Inhalation Anesthetic Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Inhalation Anesthetic Sales Market Share by Region (2017-2022)
Figure 16. Global Inhalation Anesthetic Sales Market Share by Region (2024-2028)
Figure 17. North America Inhalation Anesthetic Sales YoY (2017-2028) & (K MT)
Figure 18. North America Inhalation Anesthetic Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Inhalation Anesthetic Sales YoY (2017-2028) & (K MT)
Figure 20. Europe Inhalation Anesthetic Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Inhalation Anesthetic Sales YoY (2017-2028) & (K MT)
Figure 22. Asia-Pacific Inhalation Anesthetic Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Inhalation Anesthetic Sales YoY (2017-2028) & (K MT)
Figure 24. Latin America Inhalation Anesthetic Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Inhalation Anesthetic Sales YoY (2017-2028) & (K MT)
Figure 26. Middle East & Africa Inhalation Anesthetic Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Inhalation Anesthetic Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Inhalation Anesthetic in the World: Market Share by Inhalation Anesthetic Revenue in 2021
Figure 29. Global Inhalation Anesthetic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Inhalation Anesthetic Sales Market Share by Type (2017-2028)
Figure 31. Global Inhalation Anesthetic Revenue Market Share by Type (2017-2028)
Figure 32. Global Inhalation Anesthetic Sales Market Share by Application (2017-2028)
Figure 33. Global Inhalation Anesthetic Revenue Market Share by Application (2017-2028)
Figure 34. North America Inhalation Anesthetic Sales Market Share by Type (2017-2028)
Figure 35. North America Inhalation Anesthetic Revenue Market Share by Type (2017-2028)
Figure 36. North America Inhalation Anesthetic Sales Market Share by Application (2017-2028)
Figure 37. North America Inhalation Anesthetic Revenue Market Share by Application (2017-2028)
Figure 38. North America Inhalation Anesthetic Sales Share by Country (2017-2028)
Figure 39. North America Inhalation Anesthetic Revenue Share by Country (2017-2028)
Figure 40. U.S. Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Inhalation Anesthetic Sales Market Share by Type (2017-2028)
Figure 43. Europe Inhalation Anesthetic Revenue Market Share by Type (2017-2028)
Figure 44. Europe Inhalation Anesthetic Sales Market Share by Application (2017-2028)
Figure 45. Europe Inhalation Anesthetic Revenue Market Share by Application (2017-2028)
Figure 46. Europe Inhalation Anesthetic Sales Share by Country (2017-2028)
Figure 47. Europe Inhalation Anesthetic Revenue Share by Country (2017-2028)
Figure 48. Germany Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 49. France Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Inhalation Anesthetic Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Inhalation Anesthetic Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Inhalation Anesthetic Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Inhalation Anesthetic Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Inhalation Anesthetic Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Inhalation Anesthetic Revenue Share by Region (2017-2028)
Figure 59. China Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 62. India Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Inhalation Anesthetic Sales Market Share by Type (2017-2028)
Figure 70. Latin America Inhalation Anesthetic Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Inhalation Anesthetic Sales Market Share by Application (2017-2028)
Figure 72. Latin America Inhalation Anesthetic Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Inhalation Anesthetic Sales Share by Country (2017-2028)
Figure 74. Latin America Inhalation Anesthetic Revenue Share by Country (2017-2028)
Figure 75. Mexico Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Inhalation Anesthetic Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Inhalation Anesthetic Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Inhalation Anesthetic Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Inhalation Anesthetic Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Inhalation Anesthetic Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Inhalation Anesthetic Revenue Share by Country (2017-2028)
Figure 84. Turkey Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Inhalation Anesthetic Revenue (2017-2028) & (US$ Million)
Figure 87. Inhalation Anesthetic Value Chain
Figure 88. Inhalation Anesthetic Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed